Mark Reinwald

Performance of Galactomannan, Beta- <scp>d</scp> -Glucan, Aspergillus Lateral-Flow Device, Conventional Culture, and PCR Tests with Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis

Martin Hoenigl, Juergen Prattes, Jasmin Wagner et al. · Journal of Clinical Microbiology · 2014 · 230 citations · Full text

Norovirus gastroenteritis causes severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation

Stefan Schwartz, Maria Vergoulidou, E. Schreier et al. · Blood · 2011 · 159 citations · Full text

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial

Judith Trotman, Sally F. Barrington, David Belada et al. · The Lancet Oncology · 2018 · 152 citations · Full text

Lymphoid Neoplasia, End-of-induction Pet Response, Medicine +7

Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-center trial

Olaf Penack, Stefan Schwartz, Peter Martus et al. · Annals of Oncology · 2006 · 115 citations

Single-center Trial, Antifungal Agent, Antifungal Agents +5

Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study

Tobias Boch, Oliver A. Cornely, Jörg Janne Vehreschild et al. · Clinical Microbiology and Infection · 2016 · 103 citations · Full text

Diagnostic Mycology, Molecular Diagnostic Techniques, Antifungal Agent +10